These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 1456888)

  • 21. Characterization of virus-like particles produced by a recombinant baculovirus containing the gag gene of the bovine immunodeficiency-like virus.
    Rasmussen L; Battles JK; Ennis WH; Nagashima K; Gonda MA
    Virology; 1990 Oct; 178(2):435-51. PubMed ID: 1699349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of human immunodeficiency virus type 1 Vif with Gag and Gag-Pol precursors: co-encapsidation and interference with viral protease-mediated Gag processing.
    Bardy M; Gay B; Pébernard S; Chazal N; Courcoul M; Vigne R; Decroly E; Boulanger P
    J Gen Virol; 2001 Nov; 82(Pt 11):2719-2733. PubMed ID: 11602784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human immunodeficiency virus type 1 MA deletion mutants expressed in baculovirus-infected cells: cis and trans effects on the Gag precursor assembly pathway.
    Chazal N; Gay B; Carrière C; Tournier J; Boulanger P
    J Virol; 1995 Jan; 69(1):365-75. PubMed ID: 7983731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analyses of the requirements for the synthesis of virus-like particles by feline immunodeficiency virus gag using baculovirus vectors.
    Morikawa S; Booth TF; Bishop DH
    Virology; 1991 Jul; 183(1):288-97. PubMed ID: 1647071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional consequences of mutations in HIV-1 Gag p55 selected by CTL pressure.
    Zhang WH; Hockley DJ; Nermut MV; Jones IM
    Virology; 1994 Aug; 203(1):101-5. PubMed ID: 8030265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential budding efficiencies of human T-cell leukemia virus type I (HTLV-I) Gag and Gag-Pro polyproteins from insect and mammalian cells.
    Bouamr F; Garnier L; Rayne F; Verna A; Rebeyrotte N; Cerutti M; Mamoun RZ
    Virology; 2000 Dec; 278(2):597-609. PubMed ID: 11118382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity of recombinant Modified Vaccinia Ankara Viruses (rMVA) expressing HIV-1 Indian subtype C gag-protease and env-gp120 genes in mice.
    Kumar S; Seth P
    Viral Immunol; 2004; 17(4):574-9. PubMed ID: 15671754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-clade recognition of p55 by cytotoxic T lymphocytes in HIV-1 infection.
    McAdam S; Kaleebu P; Krausa P; Goulder P; French N; Collin B; Blanchard T; Whitworth J; McMichael A; Gotch F
    AIDS; 1998 Apr; 12(6):571-9. PubMed ID: 9583596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of infectious virus particles by transient co-expression of human immunodeficiency virus type 1 gag mutants.
    Chen YL; Ts'ai PW; Yang CC; Wang CT
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2497-501. PubMed ID: 9349470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of human immunodeficiency virus gag/pol gene products expressed by recombinant vaccinia viruses.
    Flexner C; Broyles SS; Earl P; Chakrabarti S; Moss B
    Virology; 1988 Oct; 166(2):339-49. PubMed ID: 2459842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune response to HIV-1 gag antigens induced by recombinant adenovirus vectors in mice and rhesus macaque monkeys.
    Prevec L; Christie BS; Laurie KE; Bailey MM; Graham FL; Rosenthal KL
    J Acquir Immune Defic Syndr (1988); 1991; 4(6):568-76. PubMed ID: 1902514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Localization of the Vpx packaging signal within the C terminus of the human immunodeficiency virus type 2 Gag precursor protein.
    Wu X; Conway JA; Kim J; Kappes JC
    J Virol; 1994 Oct; 68(10):6161-9. PubMed ID: 8083957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and extracellular release of human immunodeficiency virus type 1 Gag precursors by recombinant baculovirus-infected cells.
    Royer M; Hong SS; Gay B; Cerutti M; Boulanger P
    J Virol; 1992 May; 66(5):3230-5. PubMed ID: 1560545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The gag gene products of human immunodeficiency virus type 1: alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors.
    Mervis RJ; Ahmad N; Lillehoj EP; Raum MG; Salazar FH; Chan HW; Venkatesan S
    J Virol; 1988 Nov; 62(11):3993-4002. PubMed ID: 3262776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Release of virus-like particles from cells infected with poliovirus replicons which express human immunodeficiency virus type 1 Gag.
    Porter DC; Melsen LR; Compans RW; Morrow CD
    J Virol; 1996 Apr; 70(4):2643-9. PubMed ID: 8642700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Processing, assembly, and immunogenicity of human immunodeficiency virus core antigens expressed by recombinant vaccinia virus.
    Hu SL; Travis BM; Garrigues J; Zarling JM; Sridhar P; Dykers T; Eichberg JW; Alpers C
    Virology; 1990 Nov; 179(1):321-9. PubMed ID: 2219727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An alphavirus replicon particle chimera derived from venezuelan equine encephalitis and sindbis viruses is a potent gene-based vaccine delivery vector.
    Perri S; Greer CE; Thudium K; Doe B; Legg H; Liu H; Romero RE; Tang Z; Bin Q; Dubensky TW; Vajdy M; Otten GR; Polo JM
    J Virol; 2003 Oct; 77(19):10394-403. PubMed ID: 12970424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human immunodeficiency virus type 1 subtype C Gag virus-like particle boost substantially improves the immune response to a subtype C gag DNA vaccine in mice.
    Jaffray A; Shephard E; van Harmelen J; Williamson C; Williamson AL; Rybicki EP
    J Gen Virol; 2004 Feb; 85(Pt 2):409-413. PubMed ID: 14769898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a region in the Pr55gag-polyprotein essential for HIV-1 particle formation.
    von Poblotzki A; Wagner R; Niedrig M; Wanner G; Wolf H; Modrow S
    Virology; 1993 Apr; 193(2):981-5. PubMed ID: 8460500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chimeric HIV-1 virus-like particles containing gp120 epitopes as a result of a ribosomal frameshift elicit Gag- and SU-specific murine cytotoxic T-lymphocyte activities.
    Tobin GJ; Li GH; Fong SE; Nagashima K; Gonda MA
    Virology; 1997 Sep; 236(2):307-15. PubMed ID: 9325238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.